Literature DB >> 28059730

Reprogramming to resist.

Kathleen Kelly1, Steven P Balk2.   

Abstract

Mesh：

Year:  2017        PMID： 28059730     DOI： 10.1126/science.aam5355

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations.

Authors:  Adam G Sowalsky; Huihui Ye; Manoj Bhasin; Eliezer M Van Allen; Massimo Loda; Rosina T Lis; Laleh Montaser-Kouhsari; Carla Calagua; Fen Ma; Joshua W Russo; Rachel J Schaefer; Olga S Voznesensky; Zhenwei Zhang; Glenn J Bubley; Bruce Montgomery; Elahe A Mostaghel; Peter S Nelson; Mary-Ellen Taplin; Steven P Balk
Journal:  Cancer Res       Date:  2018-06-19       Impact factor: 12.701

2.  Biology and evolution of poorly differentiated neuroendocrine tumors.

Authors:  David S Rickman; Himisha Beltran; Francesca Demichelis; Mark A Rubin
Journal:  Nat Med       Date:  2017-06-06       Impact factor: 53.440

3.  Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements-a clinicopathologic and genomic sequencing-based discussion.

Authors:  Steven C Weindorf; Alexander S Taylor; Chandan Kumar-Sinha; Dan Robinson; Yi-Mi Wu; Xuhong Cao; Daniel E Spratt; Michelle M Kim; Amir Lagstein; Arul M Chinnaiyan; Rohit Mehra
Journal:  Med Oncol       Date:  2019-02-02       Impact factor: 3.064

Review 4.  Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized Therapy.

Authors:  Max Christenson; Chung-Seog Song; Ya-Guang Liu; Bandana Chatterjee
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

5.  A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer.

Authors:  Matteo Capaia; Ilaria Granata; Mario Guarracino; Andrea Petretto; Elvira Inglese; Carlo Cattrini; Nicoletta Ferrari; Francesco Boccardo; Paola Barboro
Journal:  Int J Mol Sci       Date:  2018-06-30       Impact factor: 5.923

6.  Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma.

Authors:  Paola Ostano; Maurizia Mello-Grand; Debora Sesia; Ilaria Gregnanin; Caterina Peraldo-Neia; Francesca Guana; Elena Jachetti; Antonella Farsetti; Giovanna Chiorino
Journal:  Int J Mol Sci       Date:  2020-02-06       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.